Laura Hokkanen

Laura Hokkanen

Auto-generated profile, based on publicly available information

Laura Hokkanen

Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2006 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
LHL. S. K. Hokkanen
L. S. K. Hokkanen
VKV. Kauranen
V. Kauranen
RRR. O. Roine
R. O. Roine
OSO. Salonen
O. Salonen
MKM. Kotila
M. Kotila

4 January 2011 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
PDF file
MSM. Sotaniemi
M. Sotaniemi
VPV. Pulliainen
V. Pulliainen
LHL. Hokkanen
L. Hokkanen
TPT. Pirttilä
T. Pirttilä
IHI. Hallikainen
I. Hallikainen
THT. Hänninen
T. Hänninen
Sotaniemi M, Pulliainen V, Hokkanen L, Pirttilä T, Hallikainen I, Soininen H, Hänninen T. CERAD-neuropsychological battery in screening mild Alzheimer’s disease. Acta Neurol Scand: 2012: 125: 16–23. © 2011 John Wiley & Sons A/S. Objectives – The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) neuropsychological battery (nb) is used as an evaluation tool for dementia. In Finland, CERAD-nb was introduced in 1999 and has been proposed to be used in primary health care. However, some of its parts need reassessment and focusing. The goal of this study was to examine the sensitivity and specificity of the subtests and their cut-off points most appropriate for identifying mild Alzheimer’s disease (AD). Materials and Methods – The study population consisted of 171 patients with mild AD and 315 cognitively normal elderly. Both groups underwent CERAD-nb investigation as a part of a wider examination procedure. Results – The most efficient subtests to discriminate patients with mild AD from the normal elderly were Wordlist delayed recall and savings, Wordlist learning and Wordlist recognition and a new variable of Total recall. Optimal cut-off points for each subtest are suggested. The sensitivities of the verbal memory subtests varied between 0.75 and 0.94, the specificities between 0.80 and 0.93 and the areas under the receiver operating characteristics curve between 0.89 and 0.96. Conclusions – The CERAD-nb is capable of differentiating cases with mild AD from normal elderly individuals particularly with its verbal memory subtests. New cut-off scores for CERAD’s subtests validated in the study further enhance the differentiating power, and with these clarifications, CERAD-nb is considered appropriate to be used as a screening tool for AD even in primary health care.

31 March 2008 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
LHLaura Hokkanen
Laura Hokkanen
LRLeena Rantala
Leena Rantala
ARAnne M. Remes
Anne M. Remes
BHBirgitta Härkönen
Birgitta Härkönen
PVPetteri Viramo
Petteri Viramo
IWIlkka Winblad
Ilkka Winblad

23 December 2021 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
SKSamu N. Kurki
Samu N. Kurki
JKJonas Kantonen
Jonas Kantonen
KKKarri Kaivola
Karri Kaivola
LHLaura Hokkanen
Laura Hokkanen
MMMikko I. Mäyränpää
Mikko I. Mäyränpää
LMLiisa Myllykangas
Liisa Myllykangas
Apolipoprotein E ε4 allele (APOE4) has been shown to associate with increased susceptibility to SARS-CoV-2 infection and COVID-19 mortality in some previous genetic studies, but information on the role of APOE4 on the underlying pathology and parallel clinical manifestations is scarce. Here we studied the genetic association between APOE and COVID-19 in Finnish biobank, autopsy and prospective clinical cohort datasets. In line with previous work, our data on 2611 cases showed that APOE4 carriership associates with severe COVID-19 in intensive care patients compared with non-infected population controls after matching for age, sex and cardiovascular disease status. Histopathological examination of brain autopsy material of 21 COVID-19 cases provided evidence that perivascular microhaemorrhages are more prevalent in APOE4 carriers. Finally, our analysis of post-COVID fatigue in a prospective clinical cohort of 156 subjects revealed that APOE4 carriership independently associates with higher mental fatigue compared to non-carriers at six months after initial illness. In conclusion, the present data on Finns suggests that APOE4 is a risk factor for severe COVID-19 and post-COVID mental fatigue and provides the first indication that some of this effect could be mediated via increased cerebrovascular damage. Further studies in larger cohorts and animal models are warranted.

12 December 2007 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
PDF file
ERE. Rosti-Otajärvi
E. Rosti-Otajärvi
PHP. Hämäläinen
P. Hämäläinen
KKK. Koivisto
K. Koivisto
LHL. Hokkanen
L. Hokkanen
The Multiple Sclerosis Functional Composite (MSFC) is a multidimensional measurement tool for multiple sclerosis (MS) including a measure of ambulation (Timed 25-foot Walk [TWT]), arm function (Nine-Hole Peg Test [9HPT]) and cognition (Paced Auditory Serial Addition Test [PASAT]). To assess the reliability and practice effects in the Finnish version of the MSFC and its components. Ten relapsing-remitting MS patients and 10 healthy controls underwent five testing sessions with the MSFC over a 4-week period. The MSFC showed excellent intra- (0.99) and inter-rater (1.0) reliability. The MSFC, especially the 9HPT and the PASAT showed significant practice effects. On the 9HPT the controls remained stable whereas the patients improved their performance; on the PASAT both groups improved. The MSFC showed excellent intra- and inter-rater reliability although the 9HPT and the PASAT were prone to considerable practice effects.

1 August 2007 in Neuropsychological Rehabilitation
Verified
Journal Article
Closed access
LHLaura Hokkanen
Laura Hokkanen
JLJyrki Launes
Jyrki Launes
Acute encephalitis is an inflammation of the brain parenchyma. In the USA, by estimation, 20,000 cases occur every year. A variety of cognitive deficits may persist after the acute stage, and they are often the sole cause of disability. Recent literature demonstrates the heterogeneity of both mnestic disorders and the outcome following encephalitis. Herpes simplex virus is the most commonly recognised single aetiology of sporadic encephalitis and it may be the cause of the most severe symptoms. Antiviral medication, however, seems to have improved the cognitive outcome when compared to the historical, untreated cases. The cognitive sequelae following herpes simplex virus encephalitis (HSVE) are best known and most commonly described, e.g., in textbooks, but they do not represent the typical symptomatology of encephalitis in general. Much less is unfortunately known about other types of encephalitis, those that account perhaps up to 80% of all cases, where both mild and severe defects have been observed. This article summarises the current knowledge.